Rhenman & Partners Asset Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,750
| Closed | -$909K | – | 93 |
|
|
2022
Q1 | $909K | Hold |
3,750
| – | – | 0.09% | 88 |
|
|
2021
Q4 | $1.18M | Hold |
3,750
| – | – | 0.08% | 89 |
|
|
2021
Q3 | $1.55M | Hold |
3,750
| – | – | 0.11% | 88 |
|
|
2021
Q2 | $1.15M | Hold |
3,750
| – | – | 0.08% | 93 |
|
|
2021
Q1 | $771K | Hold |
3,750
| – | – | 0.05% | 92 |
|
|
2020
Q4 | $750K | Hold |
3,750
| – | – | 0.06% | 83 |
|
|
2020
Q3 | $621K | Hold |
3,750
| – | – | 0.06% | 79 |
|
|
2020
Q2 | $930K | Hold |
3,750
| – | – | 0.1% | 81 |
|
|
2020
Q1 | $684K | Hold |
3,750
| – | – | 0.1% | 80 |
|
|
2019
Q4 | $1.09M | Hold |
3,750
| – | – | 0.12% | 81 |
|
|
2019
Q3 | $1.02M | Hold |
3,750
| – | – | 0.13% | 78 |
|
|
2019
Q2 | $1.41M | Hold |
3,750
| – | – | 0.16% | 74 |
|
|
2019
Q1 | $1.01M | Hold |
3,750
| – | – | 0.12% | 73 |
|
|
2018
Q4 | $798K | Hold |
3,750
| – | – | 0.09% | 72 |
|
|
2018
Q3 | $1.68M | Hold |
3,750
| – | – | 0.17% | 68 |
|
|
2018
Q2 | $1.52M | Hold |
3,750
| – | – | 0.16% | 71 |
|
|
2018
Q1 | $2.05M | Buy |
+3,750
| New | +$2.05M | 0.25% | 68 |
|